WuXi AppTec nets $950m from H-share tap

Jonathan Breen

July 29, 2020 08:00 AM

Chinese pharmaceutical company WuXi AppTec has raised HK$7.37bn ($950.4m) of fresh equity, in a hotly-anticipated tap of a new mandate to issue A-shares and H-shares.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

JP Morgan Equity Hong Kong SAR Asia Follow-ons and Rights Issues Asia Greater China Morgan Stanley Northeast Asia Asia Pacific Follow-ons and Rights issues Emerging Markets Goldman Sachs

JB

Jonathan Breen

Equities editor GlobalCapital Asia